Novonesis (Novozymes A/S) (NVZMY)
57.83
+0.11
(+0.19%)
USD |
OTCM |
May 19, 15:59
Novonesis (Novozymes A/S) EPS Diluted (Quarterly) : 0.4996 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| RPM International, Inc. | 0.4007 |
| Givaudan SA | -- |
| Symrise AG | -- |
| DSM-Firmenich AG | -- |
| Arq, Inc. | -0.0202 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 232.93M |
| Revenue (Quarterly) | 1.309B |
| Total Expenses (Quarterly) | 1.077B |
| Enterprise Value | 30.23B |
| Gross Profit Margin (Quarterly) | 56.66% |
| Profit Margin (Quarterly) | 17.79% |
| Earnings Yield | 2.56% |
| Operating Earnings Yield | 3.68% |
| Normalized Earnings Yield | 2.745 |